Weighted-Average Shares Outstanding (Basic): The number of shares held by shareholders including insiders but not including a company's treasury shares, sourced from the company 10-K or 10-Q SEC reports.
Xenon Pharmaceuticals Inc. (XENE) had Weighted-Average Shares Outstanding (Basic) of 87.35M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-102.30M |
|
-- |
|
-- |
|
$112.33M |
|
$-112.33M |
|
$7.46M |
|
$-104.87M |
|
$-104.87M |
|
$-102.30M |
|
$-102.30M |
|
$-102.30M |
|
$-102.30M |
|
$-112.33M |
|
$-111.74M |
|
|
Weighted-Average Shares Outstanding (Basic) |
87.35M |
87.35M |
|
$-1.17 |
|
$-1.17 |
|
| Balance Sheet Financials | |
$1.11B |
|
$8.29M |
|
$280.18M |
|
$1.39B |
|
$39.81M |
|
-- |
|
$9.18M |
|
$48.99M |
|
$1.34B |
|
$1.34B |
|
$1.34B |
|
96.62M |
|
| Cash Flow Statement Financials | |
$-88.90M |
|
$-407.28M |
|
$843.01M |
|
$199.16M |
|
$545.87M |
|
$346.70M |
|
$16.89M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
27.79 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-89.03M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-7.65% |
|
-7.65% |
|
-7.38% |
|
-7.65% |
|
$13.85 |
|
$-1.02 |
|
$-1.02 |
|